Trump administration announces new tariffs on drugmakers

The Trump administration announced 100% tariffs on patented pharmaceuticals to pressure drugmakers into lowering prices and moving manufacturing to the U.S., with exemptions for companies committing to domestic production. The tariffs aim to incentivize 'most-favored nation' pricing deals and domestic manufacturing investments, affecting major pharma hubs like China, India, and Singapore.